Doha, Qatar – Marking a decade of progress in precision medicine, Sidra Medicine, a Qatar Foundation entity, will host the highly anticipated Precision Medicine and the Future of Genomics 2024 Summit (PMFG 2024) from 3-5 December, 2024, at the Qatar National Convention Center (QNCC) in Doha.
PMFG 2024 will focus on three main pillars: Genomics for All, Precision Diagnostics, and Advanced Therapeutics. Moreover, it will bring together leading experts, innovators, and stakeholders from around the world to explore the latest advancements in these key areas of personalized healthcare.
Dr. Iyabo Tinubu-Karch, CEO of Sidra Medicine said: “Qatar is at the forefront of precision medicine, thanks to local entities like Sidra Medicine, Hamad Medical Corporation, Qatar Foundation, Qatar Precision Health Institute and other partners. Our combined efforts highlight pioneering therapies and world-class research that have ultimately positioned Qatar as an experienced healthcare organization on programs related to genetic and genomic medicine, pediatric rare diseases and precision health. I am proud that the PMFG 2024 summit, led by our researchers, will put the spotlight on how far we have come and how we are paving the way for a future where healthcare is tailored to the unique genetic makeup of Arab populations. This will ultimately improve disease prevention, treatment efficacy, and health equity.”
Dr. Ammira Akil, Principal Investigator and the lead of the Genetic and Metabolic Disorders Clinical Research Program at Sidra Medicine and Organizing Chair of PMFG 2024 said: “The future of precision medicine in Qatar will be showcased at PMFG 2024, a testament to the power of collaboration. We are bringing together the brightest minds in healthcare, research, technology, and policy to share knowledge, forge partnerships, and drive the next wave of innovation. Also, PMFG 2024 will highlight advancements in precision medicine, including newborn genome sequencing, population genomics, precise diagnostics and breakthrough therapies. The strong support from the international and national medical and scientific sponsors underscores the significance of this summit in advancing precision medicine and genomics.”
Also Read: Sidra Medicine Leads Largest Research on Rare Genetic Disease Risk in the Middle East
With a focus on ethical considerations and real-world implementation, PMFG 2024 attendees will discover how early genomic information can personalize newborn care, explore large-scale genomic advancements and their integration into healthcare systems, and also uncover targeted treatment breakthroughs for complex and rare diseases.
Renowned physician-scientist, Dr. Robert Green, who is a Professor of Medicine (Genetics) from Harvard Medical School, will be the opening keynote speaker at PMFG 2024. Dr. Green leads the MedSeq and BabySeq Projects, providing crucial early data on the clinical utility and cost-effectiveness of comprehensive genomic sequencing in newborns.
PMFG 2024 will be under the patronage of the Human Genome Organization (HUGO) and Global Alliance for Genomics and Health (GA4GH).Furthermore, partners include – The Children’s Hospital of Philadelphia (CHOP) as knowledge partner; ScieNFT as open science partner; Msheireb Museums as community partner; and 51 East as a retail partner.
PMFG 2024 is open to healthcare professionals, scientists, researchers, academic institutions, policymakers, patient advocates, and technology and solution providers. Moreover, Register now at sidra.org/pmfg2024 and be part of this transformative Summit!
